Japanese Study Involving Athersys’ MultiStem Technology Has Enrolled Its First Patient

With its partner, Healios K.K., Athersys enrolls its first patient in a study to evaluate MultiStem cell therapy treatment of patients who have suffered an ischemic stroke.

Read More  >